Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04081233
Other study ID # HSC-MS-19-0649
Secondary ID KL2TR003168
Status Completed
Phase N/A
First received
Last updated
Start date February 23, 2020
Est. completion date December 31, 2022

Study information

Verified date March 2024
Source The University of Texas Health Science Center, Houston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the usual care alone to usual care plus early surgical stabilization in adult trauma patients who have been admitted with rib fractures, to evaluate for heterogeneity of treatment effect in high risk subgroups and to determine the the impact of multiple rib fractures on post-discharge health status and time to return to work or usual physical activity.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Blunt trauma mechanism - Severe chest wall injury (defined by one of the 3 below): Radiographic flail segment (defined as greater than 2 fractures in greater than 3 consecutive ribs) or greater than 5 consecutive rib fractures or greater than 1 rib fractures with bicortical displacement - At least one true rib (1-7) fractured and accessible for stabilization Exclusion Criteria: - Severe traumatic brain injury (best resuscitated GCS less than 8 as measured at 24 hours) - Spinal cord injury - Pre-existing congestive heart failure or oxygen-dependent pulmonary disease - Any reason for which SSRF could not occur within 72 hours of admission

Study Design


Intervention

Procedure:
surgical stabilization
Surgical procedure utilizing any commercially available internal rib fixation system
Usual care
Usual care typically consists of breathing exercises and pain control,often including opioids

Locations

Country Name City State
United States The University of Texas Health Science Center at Houston Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston National Center for Advancing Translational Sciences (NCATS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hospital Length of Stay Number of days patient is in the hospital 180 days after admission
Secondary Mortality Death following trauma injury involving rib fractures 180 days after admission
Secondary Incidence of Respiratory Failure Requiring Mechanical Ventilation Greater Than 24 Hours number of patients who require mechanical ventilation greater than 24 hours 24 hours after hospital admission
Secondary Number of Patients Requiring Tracheostomy Number of patients requiring a tracheostomy due to prolonged mechanical ventilation Hospital discharge (about 20 to 30 days)
Secondary Number of Patients Who Developed Pneumonia During the Hospitalization Number of patients diagnosed with pneumonia with greater than 10,000 cfu/ml on bronchioalveolar lavage or clinical diagnosis of pneumonia with subsequent antibiotic coverage 6 months after admission
Secondary Number of Patients Who Received Regional Analgesia Number of patients utilizing regional analgesia, such as epidural, paravertebral, intercostal or serratus plane anesthesia 6 months after admission
Secondary Opioid Usage Opioid usage is reported in milligrams per patient pre-randomization Baseline
Secondary Opioid Usage Opioid usage is reported in milligrams per patient from admission to discharge Hospital discharge (about 20 to 30 days)
Secondary Ventilator Free Days Number of inpatient hospital days patients did not require mechanical ventilation Hospital discharge (about 20 to 30 days)
Secondary Intensive Care Unit (ICU) Free Days Number of inpatient hospital days patient was not in ICU in the first 30 days Hospital discharge (about 20 to 30 days)
Secondary Hospital (ICU) Free Days Number of days patient was not in the hospital during the first 30 days after admission. 30 days post admission
Secondary Re-intervention Rates for Surgical Complications The number of times a procedure was required to treat surgical complications 180 days post admission
Secondary Health Status as Assessed by Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L) Health status will be assessed by the Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). The Euro QoL 5-D 5-L VAS score is directly reported by participants and ranges from 0 (the worst imaginable health) to 100 (the best imaginable health). A higher score indicates a better outcome. 30 days post admission
Secondary Health Status as Assessed by Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L) Health status will be assessed by the Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). The Euro QoL 5-D 5-L VAS score is directly reported by participants and ranges from 0 (the worst imaginable health) to 100 (the best imaginable health). A higher score indicates a better outcome. 90 days post admission
Secondary Health Status as Assessed by Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L) Health status will be assessed by the Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). The Euro QoL 5-D 5-L VAS score is directly reported by participants and ranges from 0 (the worst imaginable health) to 100 (the best imaginable health). A higher score indicates a better outcome. 180 days post admission
Secondary Health Status as Assessed by Index Score on the Euroqol-5D-5L Health Status will be assessed by the index score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). The Euro QoL 5-D 5-L index score ranges from 0 (a state as bad as being dead) to 1 (full health), and it is a summary score based on societal preference weights for the cumulative health states measured by 5 different dimensions (Mobility, Self-care, Daily activities, Pain/Discomfort, Anxiety/ Depression). It is calculated using the 2017 United States time trade-off valuation data set. A higher score indicates a better outcome. 30 days post admission
Secondary Health Status as Assessed by Index Score on the Euroqol-5D-5L Health Status will be assessed by the index score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). The Euro QoL 5-D 5-L index score ranges from 0 (a state as bad as being dead) to 1 (full health), and it is a summary score based on societal preference weights for the cumulative health states measured by 5 different dimensions (Mobility, Self-care, Daily activities, Pain/Discomfort, Anxiety/ Depression). It is calculated using the 2017 United States time trade-off valuation data set. A higher score indicates a better outcome. 90 days post admission
Secondary Health Status as Assessed by Index Score on the Euroqol-5D-5L Health Status will be assessed by the index score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). The Euro QoL 5-D 5-L index score ranges from 0 (a state as bad as being dead) to 1 (full health), and it is a summary score based on societal preference weights for the cumulative health states measured by 5 different dimensions (Mobility, Self-care, Daily activities, Pain/Discomfort, Anxiety/ Depression). It is calculated using the 2017 United States time trade-off valuation data set. A higher score indicates a better outcome. 180 days post admission
Secondary Health Status as Indicated by Level of Impairment as Assessed by the Euroqol-5D-5L Level of impairment will be assessed for five dimensions (Mobility, Self-care, Daily activities, Pain, Anxiety) by using the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). Each dimension is rated at five levels: no impairment (1); minor impairment (2); moderate impairment (3); severe impairment (4); and extreme impairment (5). A higher score indicates a worse outcome. 30 days post admission
Secondary Health Status as Indicated by Level of Impairment as Assessed by the Euroqol-5D-5L Level of impairment will be assessed for five dimensions (Mobility, Self-care, Daily activities, Pain/Discomfort, Anxiety/ Depression) by using the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). Each dimension is rated at five levels: no impairment (1); minor impairment (2); moderate impairment (3); severe impairment (4); and extreme impairment (5). A higher score indicates a worse outcome. 90 days post admission
Secondary Health Status as Indicated by Level of Impairment as Assessed by the Euroqol-5D-5L Level of impairment will be assessed for five dimensions (Mobility, Self-care, Daily activities, Pain/Discomfort, Anxiety/ Depression) by using the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L). Each dimension is rated at five levels: no impairment (1); minor impairment (2); moderate impairment (3); severe impairment (4); and extreme impairment (5). A higher score indicates a worse outcome. 180 days post admission
Secondary Time From Injury to Return to Work Number of days from time of injury until patient was able to return to work prior to injury per patient's assessment 180 days post admission
Secondary Time From Injury to Resolution of Pain Number of days from time of injury to time patient verbalized pain was resolved 180 days post admission
Secondary Time From Injury to Return to Usual Activity Number of days from time of injury until patient was able to return to usual activities prior to injury per patient's assessment 180 days post admission
Secondary Number of Participants Prescribed Opioids at Discharge Hospital discharge (about 20 to 30 days)
Secondary Number of Participants Back to Work or Normal Physical Activity 30 days post admission
Secondary Number of Participants Back to Work or Normal Physical Activity 90 days post admission
Secondary Number of Participants Back to Work or Normal Physical Activity 180 days post admission
See also
  Status Clinical Trial Phase
Recruiting NCT04413799 - PVB vs Ketamine/Lidocaine in Rib Fracture Patients Early Phase 1
Completed NCT04536311 - Surgical Stabilization of Rib Fractures While Awake or Under Appropriate Sedation by Paravertebral Block N/A
Enrolling by invitation NCT06069154 - Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Pain Following Thoracic Trauma N/A
Recruiting NCT05865327 - UltrasouNd-guided Percutaneous Intercostal Nerve Cryoneurolysis for Analgesia Following Traumatic Rib Fracture N/A
Recruiting NCT03619785 - US-guided SAPB for Rib Fractures in the ED Phase 4
Recruiting NCT06464302 - Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized Rib Fractures
Recruiting NCT05748366 - Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures N/A
Completed NCT04311827 - Serratus Anterior Plane Block for Improving Pain and Respiratory Function in Patients With Multiple Rib Fractures
Recruiting NCT03770208 - RIB PAIN (Rib Fractures Treated With Parental Analgesia With Infused LidocaiNe) N/A
Withdrawn NCT03571919 - Lidocaine Infusions for Rib Fractures Phase 4
Terminated NCT03846024 - Orthosis of Acute Traumatic Rib Fractures Via RibFx Belt for Pain Alleviation and Improved Pulmonary Function N/A
Not yet recruiting NCT04892563 - Erector Spinae Plane Block for Rib Fracture Analgesia in the Emergency Department N/A
Completed NCT03221595 - Multicenter RCT of SSRF in Non Flail Patients N/A
Completed NCT05340517 - Prospective Study of Video-assisted Rib Planting in Chest Wall Stabilization N/A
Terminated NCT04909463 - Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma N/A
Not yet recruiting NCT03883958 - Erector Spinae Plane Block vs Paravertebral Block for Pain Management in Fractured Ribs N/A
Recruiting NCT05415384 - Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures N/A
Not yet recruiting NCT05758870 - A Prospective Randomized Controlled Study Comparing the Clinical Effects of Surgical and Non-surgical Treatment of Low Rib Fractures
Recruiting NCT04781673 - Ketamine vs Lidocaine in Traumatic Rib Fractures Phase 4
Withdrawn NCT04163224 - Minimal Invasive Approach for Surgical Repair of Rib Fractures With a Novel Intrathoracic Device